Zobrazeno 1 - 10
of 201
pro vyhledávání: '"D Riddell"'
Publikováno v:
Annals of Coloproctology, Vol 40, Iss 2, Pp 114-120 (2024)
Purpose The estimation of the risk posed by malignant polyps for residual or lymphatic disease plays a central role. This study investigated colorectal surgeons’ assessment of these risks associated with malignant polyps. Methods A cross-sectional
Externí odkaz:
https://doaj.org/article/a4c9b251f83949f29b947a5c53d74518
Publikováno v:
Pathology. 55:58-63
The treatment of colorectal malignant polyps is dependent upon quality reporting of the histopathological features known to predict the risk of residual disease or lymph node metastasis. The Royal College of Pathologists of Australasia (RCPA) has pro
Publikováno v:
ANZ Journal of Surgery. 93:932-938
Autor:
Jason A. Avery, John E. Ingeholm, Sophie Wohltjen, Meghan Collins, Cameron D. Riddell, Stephen J. Gotts, Lauren Kenworthy, Gregory L. Wallace, W. Kyle Simmons, Alex Martin
Publikováno v:
NeuroImage: Clinical, Vol 19, Iss , Pp 38-46 (2018)
Selective or ‘picky’ eating habits are common among those with autism spectrum disorder (ASD). These behaviors are often related to aberrant sensory experience in individuals with ASD, including heightened reactivity to food taste and texture. Ho
Externí odkaz:
https://doaj.org/article/e89d6fe8448b45dd807694f5c9ddb049
Autor:
Andrew P. Zammit, Seyed E. Panahi, Ian Brown, John D. Hooper, David A. Clark, Andrew D. Riddell
Publikováno v:
Colorectal Disease. 25:66-74
The management of malignant polyps is a treatment dilemma in selecting between polypectomy and colorectal resection. To assist clinicians, guidelines have been developed by the Association of Coloproctology of Great Britain and Ireland (ACPGBI) to pr
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and IrelandREFERENCES.
Patients diagnosed with a malignant polyp generally have favourable overall survival (OS) and cancer-specific survival (CSS). However, it is unclear how choice in management for malignant polyps may affect survival.Data from the Queensland Oncology R
Publikováno v:
ANZ journal of surgeryReferences.
The management of malignant polyps presents a treatment challenge between a colorectal resection and polypectomy alone. Patients managed with polypectomy alone typically undergo surveillance for recurrent or metastatic disease, however, optimal timin
Autor:
William D. Riddell
Publikováno v:
International Review of Social History. 66:389-414
This paper examines how class conflict affected US imperial expansion between 1898 and 1906. It focuses on West-Coast-based white merchant sailors and relies on union publications, legislative records, and congressional testimony to reveal how domest
Autor:
Alison Griffin, Simon Puttick, Paul Thomas, T. Cuda, Vicki L. J. Whitehall, Jennifer Borowsky, Elizabeth Ahern, Cheng Liu, Andrew D. Riddell, David Wyld, John D. Hooper, Nicholas Lyons, Matthew Burge, David A. Clark, Stephen E. Rose, Andrew R. L. Stevenson
Publikováno v:
Journal of Nuclear Medicine. 61:1576-1579
At diagnosis, 22% of colorectal cancer (CRC) patients have metastases, and 50% later develop metastasis. Peptide receptor radionuclide therapy (PRRT), such as 177Lu-PSMA-617, is used to treat metastatic prostate cancer. 177Lu-PSMA-617 targets prostat
Autor:
Stephen E. Rose, Chao Li, Paul Thomas, James C. Whisstock, Kamil A. Sokolowski, Simon Puttick, T. Cuda, Elena I. Deryugina, James P. Quigley, Cameron Snell, David Wyld, Ashleigh Parkin, Tashbib Khan, Ruby H. P. Law, Thomas Kryza, Marina Pajic, Andrew D. Riddell, Brian W.C. Tse, Madeline Gough, Yaowu He, John D. Hooper, Nicholas Lyons, Andrew Barbour, Julia Yin
Publikováno v:
Theranostics
Background: CUB domain-containing protein 1 (CDCP1) is a cell surface receptor regulating key signalling pathways in malignant cells. CDCP1 has been proposed as a molecular target to abrogate oncogenic signalling pathways and specifically deliver ant